Biohit Oyj Annual Financial Report March 22, 2023 at 09:30 am local time (EET)
Biohit Oyj's Annual Report 2022 is published today in PDF and XHTML format. The
annual report contains financial statements for 2022, the Report of the Board of
Directors and Corporate Governance Statements. Information in ESEF format has
not been audited. Annual report is published in Finnish and English, and it can
be read and downloaded from Biohit company website:
Annual Reports - Biohit
Healthcare (https://www.biohithealthcare.com/en/investors/annual-reports/)
CEO Jussi Hahtela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://www.biohithealthcare.com/en/)
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's
mission is “Innovating for Health” - we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=c5rWy
QltbzVNETEAzPUZ5WLkdGhFEQ1oTBo35iEHNX8xhFJ8UXxKcBfwNUj1oaJLkJWDIfhT0_qN_43uOPrHsI
IWy25pE_7iX8aTY-nisGmlggNS87UH1ViJkQ-0ezca)